CClinicalTrials.gg
CompletedNCT04837794Updated Apr 8, 2021

Self-Management of Chronic Pain

An observational study in Chronic Pain, sponsored by Lund University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-08.

Sponsored by Lund University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
15
Ages
18 Years and older
Sex
All
01

Study summary

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Read the detailed description

Chronic pain is today an increasing health problem in both Europe and US, with an estimation of about 90 million people affected in Europe (Breivik, H. et al., 2006) and 100 million people in US (Relieving Pain in America, IOM Report 2011), or 20-30% of the adult population around the world. Chronic pain is defined as a condition that lasts for at least three to six months, after the normal healing period of an injury. Medical interventions offered in clinics around the globe are unfortunately not giving the results needed to give back the quality of life the patients had prior to the onset of the pain. The treatments offered today do sometimes reduce pain, but the effect is minor, and new treatment regimens are needed (Relieving Pain in America, 2011). Recent quality assurance registry measurements in Sweden has shown that patient taken part of multi modal treatment regimens, such as the acceptance and commitment therapy, (ACT) show that less then 40% of the patients have a decline in the pain level of 1 level on the VAS scale, 55% has no effect and 9 % has an increased level of pain after going through the program (Nationel Register for Pain Rehabilitation, Sweden 2017) The study objective is to evaluate how the use of a digital pain coach, based on artificial intelligence that improves the self-management of pain will decrease the pain interference and thereby increase QoL among chronic pain patients, as measured by PROMIS pain interference 6a. We will here compare the improvement of quality of life by a decrease in pain interference, measured by PROMIS, in patients who follow their traditional treatment plan provided by the Pain Clinic with the addition of using a web application for increased self management of pain. The theory behind the study and the development of the device is supported by previously known data, showing that self-management has an effect and is important to the treatment by helping patients to believe in their own capacity to control their pain.

The present investigation aims at exploring the effect of including digital tool as an add on to standard treatment and rehabilitation and will measure the effect it has on:

Decreased pain interference Improved management of long-term pain and its consequences. Hence self-management of pain Increased function in daily life with the best possible activity and participation level Improved experience of health-related quality of life Decreased pain experience

02

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • self management
  • e-health
  • health tech
  • Digital Pain-Management Tool
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 15 is below the median of 126 across 688 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Lund University is the lead sponsor of 230 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with chronic pain patients at the UCSD Health System- Center for pain Medicine

Inclusion criteria

  • Have a complex, prolonged (neck shoulder pain or lower back pain
  • Have been followed by a pain management specialist for at least 6 months
  • Referred for Pain Medicine Consultation
  • Be >18 years of age
  • Be able to travel to and from the clinic
  • Have a goal and motivation that is adequate in relation to the program offered
  • Be medically prepared and not have any other medical examination or ongoing disease that constitutes an obstacle as well as adequate pharmacological treatment
  • Have no major change in pain management (e.g. medications)
  • Own a smart phone, tablet or computer or have the knowledge to use one

Exclusion criteria

Exclusion Criteria:

  • Low back pain requiring surgical intervention in the next 3 months
  • Severe or acute psychiatric illness, severe anxiety or depression
  • Reported/acute psychiatric illness or acute crisis
  • Ongoing abuse of alcohol, drugs and drug-based drugs. This also includes high doses of prescribed drugs
  • Pain related to malignancy
  • Other areas of pain exceeding the level/intensity of low back or neck pain
  • Currently involved in a lawsuit or pending litigation in relation to the low back or neck pain
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
15 participants (actual)
Patient registry
No

Interventions

  • DeviceDigital Pain-Management Tool

    Digital Pain-Management Tool

06

What researchers measure

Primary outcomes

  1. Pain interference

    Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 6a . Measure of the amount of interference pain causes in life; range 6-30; higher is worse

    Time frame: 6 and 12 weeks from baseline

Secondary outcomes

  1. Pain severity

    Change from Baseline in the 7 day average pain intensity. Measured by NRS using an 11-point Pain Intensity Numerical Rating Scale (NRS) (0=no pain, 10=pain as bad as you can imagine)

    Time frame: 6 and 12 weeks from baseline

  2. Physical function

    Change from baseline in physical function, measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Physical function 10a. Measure of the impact of a condition on physical function; range 4-20; higher is worse

    Time frame: 6 and 12 weeks from baseline

  3. Depression

    Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression 4a. Measures the extent to which patients experience depressive symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of depression

    Time frame: 6 and 12 weeks from baseline

  4. Anxiety

    Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Anxiety 4. Measures the extent to which patients experience anxiety symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of anxiety.

    Time frame: 6 and 12 weeks from baseline

07

Study locations

1 site
  • UC San Diego Health - Koman Family Outpatient Pavilion
    La Jolla, California 92037, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04837794
Lead sponsor
Lund University
Collaborators
University of California, San Diego, PainDrainer AB
Responsible party
Sponsor
First posted
Apr 8, 2021
Start date
Aug 1, 2019
Primary completion
Jan 30, 2021
Completion
Jan 30, 2021
Last update
Apr 8, 2021

Study contacts

Gregory R Polston, MD
principal investigator · UC San Diego Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion